Home Privacy Archive Realtime Report

Stock Trading History of Meade Harry

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Meade Harry since year 2005. The trader's CIK number is 1241322. At the time of this reporting, Meade Harry is the SVP, Transgenic Research of Gtc Biotherapeutics Inc (stock ticker symbol GTCB).

Stock purchases, sales, and option exercises reported by *Meade Harry* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-12-14	GTCB	Gtc Biotherapeutics Inc	Purchase	10,000	.90	9,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meade Harry (SVP, Transgenic Research of Gtc Biotherapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.